Literature DB >> 24100872

Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.

Nagalingeswaran Kumarasamy1, Sheela Krishnan.   

Abstract

PURPOSE OF REVIEW: With the availability of antiretroviral drugs in resource-limited settings, there is a rapid scale-up of antiretroviral therapy in developing countries. RECENT
FINDINGS: The review focuses on the issues faced while patients are on first-line antiretroviral therapy in the absence of viral load monitoring, and the availability and progress of the second-line antiretroviral drugs and the salvage regimens in resource-limited settings.
SUMMARY: There is an urgent need for low-cost, low-tech viral load monitoring in resource-limited settings. Fixed-dose combination of antiretrovirals for first-line and second-line therapy will result in better effectiveness. There is a need for newer antiretroviral drugs in resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100872     DOI: 10.1097/COH.0000000000000004

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  12 in total

1.  Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.

Authors:  Zachary S Martinez; Edison Castro; Chang-Soo Seong; Maira R Cerón; Luis Echegoyen; Manuel Llano
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Growing challenges for HIV programmes in Asia: clinic population trends, 2003-2013.

Authors:  Nicole L De La Mata; Nagalingeswaran Kumarasamy; Penh Sun Ly; Oon Tek Ng; Kinh Van Nguyen; Tuti Parwati Merati; Man Po Lee; Cuong Duy Do; Jun Yong Choi; Jeremy L Ross; Matthew G Law
Journal:  AIDS Care       Date:  2017-01-29

3.  Fullerenes in Biology and Medicine.

Authors:  Edison Castro; Andrea Hernandez Garcia; Gerardo Zavala; Luis Echegoyen
Journal:  J Mater Chem B       Date:  2017-07-08       Impact factor: 6.331

4.  Improved survival in HIV treatment programmes in Asia.

Authors:  Nicole L De La Mata; Nagalingeswaran Kumarasamy; Vohith Khol; Oon Tek Ng; Kinh Van Nguyen; Tuti Parwati Merati; Thuy Thanh Pham; Man Po Lee; Nicolas Durier; Matthew Law
Journal:  Antivir Ther       Date:  2016-02-10

5.  Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific.

Authors:  J Ross; A Jiamsakul; N Kumarasamy; I Azwa; T P Merati; C D Do; M P Lee; P S Ly; E Yunihastuti; K V Nguyen; R Ditangco; O T Ng; J Y Choi; S Oka; A H Sohn; M Law
Journal:  HIV Med       Date:  2020-11-05       Impact factor: 3.180

6.  Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naïve Patients with HIV Infection: A Retrospective Cohort Analysis.

Authors:  Jianjun Sun; Li Liu; Jiayin Shen; Tangkai Qi; Zhenyan Wang; Wei Song; Renfang Zhang; Hongzhou Lu
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

7.  Simplified clinical prediction scores to target viral load testing in adults with suspected first line treatment failure in Phnom Penh, Cambodia.

Authors:  Johan van Griensven; Vichet Phan; Sopheak Thai; Olivier Koole; Lutgarde Lynen
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

8.  From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults.

Authors:  Ivan Namakoola; Ivan Kasamba; Billy N Mayanja; Patrick Kazooba; Joseph Lutaakome; Fred Lyagoba; Anne A Kapaata; Pontiano Kaleebu; Paula Munderi
Journal:  BMC Res Notes       Date:  2016-12-23

9.  A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy.

Authors:  Marcelo J Wolff; Mark J Giganti; Claudia P Cortes; Pedro Cahn; Beatriz Grinsztejn; Jean W Pape; Denis Padgett; Juan Sierra-Madero; Eduardo Gotuzzo; Stephany N Duda; Catherine C McGowan; Bryan E Shepherd
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

10.  High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia.

Authors:  Birkneh Tilahun Tadesse; Natalie N Kinloch; Bemuluyigza Baraki; Hope R Lapointe; Kyle D Cobarrubias; Mark A Brockman; Chanson J Brumme; Byron A Foster; Degu Jerene; Eyasu Makonnen; Eleni Aklillu; Zabrina L Brumme
Journal:  Viruses       Date:  2018-02-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.